We help the life sciences industry engage with NICE and the healthcare system to speed up market access.
Getting a technology adopted in the healthcare system can be time-consuming and complex.
Engage with NICE and other key stakeholders from the healthcare system as you develop your market access strategy.
We enable companies at all stages of product development and commercialisation to gain valuable insights. These can help you get new and innovative products adopted as quickly as possible.
Helping to inform your market access strategy
Understand the changing healthcare landscape
The healthcare landscape is constantly evolving. This can make it difficult to stay informed about the most appropriate individuals and organisations to engage with.
We can help you understand the impact on your technology of initiatives such as the early access to medicines scheme (EAMS), the Accelerated Access Review (AAR), the life sciences strategy (LSS) and much more.
Identify the most appropriate route to NHS access
Understanding and engaging with the different evaluation routes to NHS access and the wider system can be challenging. We can help you navigate the differing approaches and consider the implications for your technology.
Explore your value proposition with system stakeholders
Achieving value for patients and the NHS is key to transforming healthcare. By engaging with system stakeholders early you can help ensure you are developing the new technologies and approaches that are needed.
We can help you in this important area of product development and market access planning.
How we work
Engagement meetings in a safe harbour environment
We bring together the best people to help you gain insight for your market access planning.
Working with you to understand the market access insights you're looking for.
Identifying the best people in the healthcare system to engage with.
Organising and facilitating discussions in a confidential setting.
Engaging with us early in your planning could help you optimise your market access approach.
Our engagement meetings are conducted in a safe harbour environment. This ensures a confidential, free-flowing discussion with relevant stakeholders from the healthcare system.
We tailor all meetings to your requirements. These meetings carry a fee-for-service, not for profit charge.
OMA services are provided outside of the guidance producing programmes at NICE to ensure there are no conflicts of interest.
We're here to help the NHS adopt new technologies and to foster innovation and growth in the UK’s life science industries. By facilitating engagement between life science companies and the healthcare system, we promote understanding of what will get products to patients faster.
Make informed product development decisions to help get products to patients faster.
Improve the rate at which drugs, devices and diagnostics get adopted.